{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ha JH"],"funding":["Agency for Defense Development (ADD)"],"pagination":["777"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12563112"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["11(10)"],"pubmed_abstract":["Antibodies are indispensable for protection against biological toxins and pathogens, yet their conventional liquid formulations impose severe constraints, including dosing inaccuracy caused by residual fluid remaining in the syringe and limited user convenience such as pain caused by fluid-induced tissue distension and nerve stimulation as well as instability in ambient temperature, and the requirement for low-temperature storage and logistics. These limitations critically impair rapid deployment during golden hour following acute exposure. Here, we report an antibody-integrated solid-to-gel microfilm-demonstrated with a 100 µg anti-BoNT/A dose-jet-printed and low-temperature dried directly onto metal needles for consistent, on-demand use. Upon intradermal insertion, the microfilm fully di"],"journal":["Gels (Basel, Switzerland)"],"pubmed_title":["Antibody-Integrated Solid-to-Gel Microfilm for Protection Against Botulinum Neurotoxin Type A."],"pmcid":["PMC12563112"],"funding_grant_id":["Defense Acquisition Program Administration (DAPA) in 2025 (No. 915063201)"],"pubmed_authors":["Song YJ","Kang BH","Yoon Y","Jeong JH","Lim JS","Jeon S","Kim H","Ha JH","Hwang SH","Lee YW"],"additional_accession":[]},"is_claimable":false,"name":"Antibody-Integrated Solid-to-Gel Microfilm for Protection Against Botulinum Neurotoxin Type A.","description":"Antibodies are indispensable for protection against biological toxins and pathogens, yet their conventional liquid formulations impose severe constraints, including dosing inaccuracy caused by residual fluid remaining in the syringe and limited user convenience such as pain caused by fluid-induced tissue distension and nerve stimulation as well as instability in ambient temperature, and the requirement for low-temperature storage and logistics. These limitations critically impair rapid deployment during golden hour following acute exposure. Here, we report an antibody-integrated solid-to-gel microfilm-demonstrated with a 100 µg anti-BoNT/A dose-jet-printed and low-temperature dried directly onto metal needles for consistent, on-demand use. Upon intradermal insertion, the microfilm fully di","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Sep","modification":"2026-05-15T03:18:13.198Z","creation":"2026-05-15T03:11:51.427Z"},"accession":"S-EPMC12563112","cross_references":{"pubmed":["41149382"],"doi":["10.3390/gels11100777"]}}